These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11692446)

  • 21. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 22. Individualisation of HIV therapy: the clinician's perspective.
    Gazzard BG; Moyle GJ
    Br J Clin Pract; 1995; 49(3):145-7. PubMed ID: 7779666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychological issues in patients with PHI.
    Res Initiat Treat Action; 2002; 7(2):28. PubMed ID: 11965927
    [No Abstract]   [Full Text] [Related]  

  • 24. PA update: DHHS guidelines for the treatment of HIV infection.
    Young B; Carmichael JK; Johnson D; Mills T
    JAAPA; 2006 Jan; Suppl():3-13. PubMed ID: 16429963
    [No Abstract]   [Full Text] [Related]  

  • 25. Literacy, self-efficacy, and HIV medication adherence.
    Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
    Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Highly active antiretroviral therapy--update 2008].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():4-7. PubMed ID: 19031559
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA notifications. FDA provides important information for clinicians serving hurricane victims.
    AIDS Alert; 2005 Nov; 20(11):129. PubMed ID: 16363049
    [No Abstract]   [Full Text] [Related]  

  • 28. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
    Luszczynska A; Sarkar Y; Knoll N
    Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
    Verweel G; Saavedra-Lozano J; van Rossum AM; Ramilo O; de Groot R
    Pediatr Infect Dis J; 2006 Nov; 25(11):987-94. PubMed ID: 17072119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ninth annual HIV drug guide.
    Posit Aware; 2005; 16(1):21-47. PubMed ID: 17390504
    [No Abstract]   [Full Text] [Related]  

  • 31. The meantime blues.
    Nass HM
    Posit Aware; 2005; 16(1):16-7. PubMed ID: 17390502
    [No Abstract]   [Full Text] [Related]  

  • 32. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.
    Hiransuthikul N; Hiransuthikul P; Nelson KE; Jirawisit M; Paewplot R; Kasak S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1208-15. PubMed ID: 16438147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral update: further validation of the guidelines.
    Boyle BA
    AIDS Read; 2006 Feb; 16(2):83-6. PubMed ID: 16471274
    [No Abstract]   [Full Text] [Related]  

  • 34. Switching antiretroviral therapy: why, when and how.
    Wilkin T; Glesby M; Gulick RM
    IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiretroviral choices under the DHHS guidelines.
    Boyle BA
    AIDS Read; 2004 Feb; 14(2):71-4, 77. PubMed ID: 14997862
    [No Abstract]   [Full Text] [Related]  

  • 36. Using baseline CD4 cell count and plasma HIV RNA to guide the initiation of highly active antiretroviral therapy.
    Wood E; Hogg RS; Yip B; Harrigan PR; Montaner JS
    Rev Invest Clin; 2004; 56(2):232-6. PubMed ID: 15377076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The keys to antibiotic therapy decision making in daily practice].
    Schlemmer B
    Rev Prat; 2003 Sep; 53(14):1533-44. PubMed ID: 15185660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of infection caused by human immunodeficiency virus in the Russian Federation].
    Kravchenko AV; Iurin OG; Beliaeva VV; Pokrovskiĭ VV
    Ter Arkh; 2009; 81(4):64-9. PubMed ID: 19514425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.